Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
N/A
377 Added 120.45%
690 $5,000
Q3 2023

Oct 30, 2023

BUY
N/A
377 Added 120.45%
690 $5,000
Q2 2023

May 21, 2024

SELL
$7.79 - $10.69 $62 - $85
-8 Reduced 2.49%
313 $2,000
Q2 2023

Jul 27, 2023

SELL
$7.79 - $10.69 $62 - $85
-8 Reduced 2.49%
313 $3,000
Q1 2023

May 21, 2024

BUY
$7.32 - $10.85 $592 - $878
81 Added 33.75%
321 $3,000
Q1 2023

Apr 27, 2023

BUY
$7.32 - $10.85 $592 - $878
81 Added 33.75%
321 $3,000
Q4 2022

May 21, 2024

BUY
$7.84 - $11.68 $1,881 - $2,803
240 New
240 $1,000
Q4 2022

Jan 31, 2023

BUY
$7.84 - $11.68 $141 - $210
18 Added 8.11%
240 $2,000
Q3 2022

Oct 21, 2022

BUY
$10.73 - $20.07 $2,382 - $4,455
222 New
222 $2,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.